Approval · Notice of Compliance 2935 · 1998
GABAPENTIN: Notice of Compliance 2935
Issued August 26, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2935
- Date
- August 26, 1998
- Company
- Omni Laboratories
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-epileptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GABAPENTIN | 02238671 | Cancelled Pre Market |
| GABAPENTIN | 02238672 | Cancelled Pre Market |
| GABAPENTIN | 02238673 | Cancelled Pre Market |
Medicinal ingredients
- GABAPENTIN 100 MG per CAP
- GABAPENTIN 300 MG per CAP
- GABAPENTIN 400 MG per CAP